Bernstein raises PT on CVS on turnaround progress
View all comments(0)
Bernstein raises PT on CVS Health CVS.N to $106 from $94; reiterates "outperform" rating
Brokerage says CVS is "executing on its turnaround," with recovery at Aetna, its health insurance business, "proceeding effectively"
"We see Aetna earnings nearly doubling over the next 3 years as Medicare Advantage margins continue to normalize through disciplined pricing" - Bernstein
Adds that the health insurer's Q1 was strong, driven by Aetna "outperformance"; stable retail gross margins offset expected margin pressure at its pharmacy benefit manager business
Including session's move, CVS up 16.8% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

SK Hynix Surges 15% to New High: HBM Shortage Until 2028, How Much Longer Can AI Memory King Rise?

PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.